The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma

Journal of Pathology

Volumn 223, Issue 4, 2011, Pages 519-530

  Li, Tong ^a,b   Li, Hui ^b   Wang, Yucheng ^a   Harvard, Chansonette ^c   Tan, Jia Li ^d,e   Au, Alfred ^f   Xu, Zhidong ^a   Jablons, David M ^a   You, Liang ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^d FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Akt; CXCL12; CXCR4; CXCR7; mesothelioma

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR7; MAMMALIAN TARGET OF RAPAMYCIN; PLERIXAFOR; PROTEIN KINASE B; STROMAL CELL DERIVED FACTOR 1;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CELL PROLIFERATION; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG TARGETING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT MESOTHELIOMA; MESOTHELIUM CELL; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

CELL PROLIFERATION; CELL SURVIVAL; CHEMOKINE CXCL12; HETEROCYCLIC COMPOUNDS; HUMANS; MESOTHELIOMA; NEOPLASM PROTEINS; ONCOGENE PROTEIN V-AKT; PLEURAL NEOPLASMS; RECEPTORS, CXCR; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; TOR SERINE-THREONINE KINASES; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 79551704651     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.2829     Document Type: Article

References (51)

1. Bueno R,. Mesothelioma clinical presentation. Chest 1999; 116: 444S-445S. (Pubitemid 30013153)
2. Nowak R, Mrozek S, Miecznikowski W,. The radiometric analysis of the chest and spine deformity following surgical treatment of idiopathic scoliosis by the C-D method. Ortop Traumatol Rehabil 2002; 4: 559-566.
3. Kucia M, Jankowski K, Reca R, et al., CXCR4-SDF-1 signalling, locomotion, chemotaxis and adhesion. J Mol Histol 2004; 35: 233-245. (Pubitemid 40585309)
4. Salvucci O, Yao L, Villalba S, et al., Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1. Blood 2002; 99: 2703-2711. (Pubitemid 34525355)
5. Muller A, Homey B, Soto H, et al., Involvement of chemokine receptors in breast cancer metastasis. Nature 2001; 410: 50-56. (Pubitemid 32225831)
6. Yoshitake N, Fukui H, Yamagishi H, et al., Expression of SDF-1 alpha and nuclear CXCR4 predicts lymph node metastasis in colorectal cancer. Br J Cancer 2008; 98: 1682-1689. (Pubitemid 351684689)
7. Bajetto A, Barbieri F, Pattarozzi A, et al., CXCR4 and SDF1 expression in human meningiomas: a proliferative role in tumoral meningothelial cells in vitro. Neuro Oncol 2007; 9: 3-11. (Pubitemid 46543483)
8. Dewan MZ, Ahmed S, Iwasaki Y, et al., Stromal cell-derived factor-1 and CXCR4 receptor interaction in tumor growth and metastasis of breast cancer. Biomed Pharmacother 2006; 60: 273-276. (Pubitemid 44223937)
9. Baggiolini M,. Chemokines and leukocyte traffic. Nature 1998; 392: 565-568. (Pubitemid 28207705)
10. Luster AD,. Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-445. (Pubitemid 28135672)
11. Zlotnik A, Yoshie O,. Chemokines, a new classification system and their role in immunity. Immunity 2000; 12: 121-127. (Pubitemid 30398626)
12. Schimanski CC, Galle PR, Moehler M,. Chemokine receptor CXCR4-prognostic factor for gastrointestinal tumors. World J Gastroenterol 2008; 14: 4721-4724.
13. Koizumi K, Hojo S, Akashi T, et al., Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007; 98: 1652-1658. (Pubitemid 47487897)
14. Zlotnik A,. New insights on the role of CXCR4 in cancer metastasis. J Pathol 2008; 215: 211-213. (Pubitemid 351956701)
15. Kim J, Takeuchi H, Lam ST, et al., Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 2005; 23: 2744-2753. (Pubitemid 46179464)
16. Matsusue R, Kubo H, Hisamori S, et al., Hepatic stellate cells promote liver metastasis of colon cancer cells by the action of SDF-1/CXCR4 axis. Ann Surg Oncol 2009; 16: 2645-2653.
17. Ottaiano A, Franco R, Aiello Talamanca A, et al., Overexpression of both CXC chemokine receptor 4 and vascular endothelial growth factor proteins predicts early distant relapse in stage II-III colorectal cancer patients. Clin Cancer Res 2006; 12: 2795-2803.
18. Balabanian K, Lagane B, Infantino S, et al., The chemokine SDF-1/CXCL12 binds to and signals through the orphan receptor RDC1 in T lymphocytes. J Biol Chem 2005; 280: 35760-35766. (Pubitemid 41532769)
19. Burns JM, Summers BC, Wang Y, et al., A novel chemokine receptor for SDF-1 and I-TAC involved in cell survival, cell adhesion, and tumor development. J Exp Med 2006; 203: 2201-2213. (Pubitemid 44352240)
20. Miao Z, Luker KE, Summers BC, et al., CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor associated vasculature. Proc Natl Acad Sci U S A 2007; 104: 15735-15740. (Pubitemid 350035369)
21. Wang J, Shiozawa Y, Wang J, et al., The role of CXCR7/RDC1 as a chemokine receptor for CXCL12/SDF-1 in prostate cancer. J Biol Chem 2008; 283: 4283-4294.
22. Meijer J, Ogink J, Roos E,. Effect of the chemokine receptor CXCR7 on proliferation of carcinoma cells in vitro and in vivo. Br J Cancer 2008; 99: 1493-1501.
23. Li Q, Bavikatty N, Michael CW,. The role of immunohistochemistry in distinguishing squamous cell carcinoma from mesothelioma and adenocarcinoma in pleural effusion. Semin Diagn Pathol 2006; 23: 15-19. (Pubitemid 44415395)
24. Koizumi K, Hojo S, Akashi T, et al., Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 2007; 98: 1652-1658. (Pubitemid 47487897)
25. Ishida T, Utsunomiya A, Iida S, et al., Clinical significance of CCR4 expression in adult T-cell leukemia/lymphoma: its close association with skin involvement and unfavorable outcome. Clin Cancer Res 2003; 9: 3625-3634. (Pubitemid 37169227)
26. Uchida H, Iwashita Y, Sasaki A, et al., Chemokine receptor CCR6 as a prognostic factor after hepatic resection for hepatocellular carcinoma. J Gastroenterol Hepatol 2006; 21: 161-168.
27. Mashino K, Sadanaga N, Yamaguchi H, et al., Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma. Cancer Res 2002; 62: 2937-2941. (Pubitemid 34525782)
28. Klatte T, Seligson DB, Leppert JT, et al., The chemokine receptor CXCR3 is an independent prognostic factor in patients with localized clear cell renal cell carcinoma. J Urol 2008; 179: 61-66. (Pubitemid 350216740)
29. Jiang YP, Wu XH, Shi B, et al., Expression of chemokine CXCL12 and its receptor CXCR4 in human epithelial ovarian cancer: an independent prognostic factor for tumor progression. Gynecol Oncol 2006; 103: 226-233. (Pubitemid 44374693)
30. Laverdiere C, Hoang BH, Yang R, et al., Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res 2005; 11: 2561-2567. (Pubitemid 40569454)
31. Kim J, Takeuchi H, Lam ST, et al., Chemokine receptor CXCR4 expression in colorectal cancer patients increases the risk for recurrence and for poor survival. J Clin Oncol 2005; 23: 2744-2753. (Pubitemid 46179464)
32. Schimanski CC, Schwald S, Simiantonaki N, et al., Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 2005; 11: 1743-1750. (Pubitemid 40471835)
33. Scala S, Ottaiano A, Ascierto PA, et al., Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 2005; 11: 1835-1841. (Pubitemid 40471847)
34. Monteagudo C, Martin JM, Jorda E, et al., CXCR3 chemokine receptor immunoreactivity in primary cutaneous malignant melanoma: correlation with clinicopathological prognostic factors. J Clin Pathol 2007; 60: 596-599. (Pubitemid 46975211)
35. Staller P, Sulitkova J, Lisztwan J, et al., Chemokine receptor CXCR4 downregulated by von Hippel-Lindau tumour suppressor pVHL. Nature 2003; 425: 307-313.
36. Rollins BJ,. Chemokines. Blood 1997; 3: 909-928. (Pubitemid 27314123)
37. Hattermann K, Held-Feindt J, Lucius R, et al., The chemokine receptor CXCR7 is highly expressed in human glioma cells and mediates antiapoptotic effects. Cancer Res 2010; 70: 3299-3308.
38. Iwakiri S, Mino N, Takahashi T, et al., Higher expression of chemokine receptor CXCR7 is linked to early and metastatic recurrence in pathological stage I nonsmall cell lung cancer. Cancer 2009; 115: 2580-2593.
39. Sierro F, Biben C, Martínez-Muñoz L, et al., Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc Natl Acad Sci U S A 2007; 104: 14759-14764. (Pubitemid 350003216)
40. Gerrits H, van Ingen Schenau DS, Bakker NE, et al., Early postnatal lethality and cardiovascular defects in CXCR7-deficient mice. Genesis 2008; 46: 235-245. (Pubitemid 351961759)
41. Schönemeier B, Kolodziej A, Schulz S, et al., Regional and cellular localization of the CXCl12/SDF-1 chemokine receptor CXCR7 in the developing and adult rat brain. J Comp Neurol 2008; 510: 207-220.
42. Shaw RJ, Cantley LC,. Ras, PI(3)K and mTOR signalling controls tumour cell growth. Nature 2006; 441: 424-430. (Pubitemid 44050136)
43. Davies MA, Stemke-Hale K, Lin E, et al., Integrated molecular and clinical analysis of AKT activation in metastatic melanoma. Clin Cancer Res 2009; 15: 7538-7546.
44. Guertin DA, Sabatini DM,. An expanding role for mTOR in cancer. Trends Mol Med 2005; 11: 353-361. (Pubitemid 41080576)
45. Yoshizawa A, Fukuoka J, Shimizu S, et al., Overexpression of phospho-eIF4E is associated with survival through AKT pathway in non-small cell lung cancer. Clin Cancer Res 2010; 16: 240-248.
46. Sarbassov DD, Guetin DA, Ali SM, et al., Phosphorylation and regulation of Akt/PKB by the rector-mTOR complex. Science 2005; 307: 1098-1101. (Pubitemid 40262113)
47. Schols D, Struyf S, Van Damme J, et al., Inhibition of T-tropic HIV strains by selective antagonization of the chemokine receptor CXCR4. J Exp Med 1997; 186: 1383-1388. (Pubitemid 27469034)
48. Brown EJ, Beal PA, Keith CT, et al., Control of p70 s6 kinase by kinase activity of FRAP in vivo. Nature 1995; 377: 441-446.
49. Brunn GJ, Hudson CC, Sekulic A, et al., Phosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin. Science 1997; 277: 99-101. (Pubitemid 27450655)
50. Grove JR, Banerjee P, Balasubramanyam A, et al., Cloning and expression of two human p70 S6 kinase polypeptides differing only at their amino termini. Mol Cell Biol 1991; 11: 5541-5550. (Pubitemid 21895320)
51. Pause A, Belsham GJ, Gingras AC, et al., Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 50-cap function. Nature 1994; 371: 762-767.